Literature DB >> 30034828

Novel Asymmetrical Linear Stapler (NALS) for pathologic evaluation of true resection margin tissue.

Shin-Kwang Kang1, Jin San Bok1, Hyun Jin Cho1, Min-Woong Kang1.   

Abstract

BACKGROUND: The use of limited resection for lung cancer has increased with the accumulation of knowledge about early lung cancer. To decrease locoregional recurrence after a limited resection, it is important to confirm R0 resection at the true resection margin. In this study, we report a novel linear stapler that preserves the true resection margin tissue after organ resection.
METHODS: We used a Novel Asymmetrical Linear Stapler (NALS) made by Meditulip. On the resected organ side of NALS, there is a single row of titanium fasteners. To verify the utility of NALS and to compare its preservation of the resection margin tissue to a conventional stapler, we performed wedge resection of the lung in a porcine animal model and examined the pathology of the true resection margin.
RESULTS: Using NALS, we successfully divided and closed the lung tissues, as with the conventional stapler. There was no bleeding on either side or no air leakage from the remnant stapled tissue. The distance between the cutting edge and the titanium fasteners was 3.10 mm with NALS, which was sufficient to resect the true resection margin tissue for pathology evaluation. There was no squeezing artifact at the true resection margin on microscopic evaluation with NALS. With the conventional stapler, it is difficult to evaluate the pathology at the true resection margin due to the severe squeezing artifact.
CONCLUSIONS: NALS preserves the true resection margin tissue and thus should be useful for evaluating the resection margin with a frozen section biopsy in oncology surgery.

Entities:  

Keywords:  Non-small cell lung cancer (NSCLC); limited resection; resection margin; surgical stapler

Year:  2018        PMID: 30034828      PMCID: PMC6035920          DOI: 10.21037/jtd.2018.03.158

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  23 in total

1.  Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer.

Authors:  Matthew J Schuchert; Brian L Pettiford; Samuel Keeley; Thomas A D'Amato; Arman Kilic; John Close; Arjun Pennathur; Ricardo Santos; Hiran C Fernando; James R Landreneau; James D Luketich; Rodney J Landreneau
Journal:  Ann Thorac Surg       Date:  2007-09       Impact factor: 4.330

2.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

3.  Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study.

Authors:  K Kodama; O Doi; M Higashiyama; H Yokouchi
Journal:  J Thorac Cardiovasc Surg       Date:  1997-09       Impact factor: 5.209

Review 4.  Limited resection in the treatment of stage I non-small cell lung cancer; an overview.

Authors:  R J Ginsberg
Journal:  Chest       Date:  1989-07       Impact factor: 9.410

5.  Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules.

Authors:  Jong Ho Cho; Yong Soo Choi; Jhingook Kim; Hong Kwan Kim; Jae Ill Zo; Young Mog Shim
Journal:  Ann Thorac Surg       Date:  2014-11-15       Impact factor: 4.330

6.  History of limited resection for non-small cell lung cancer.

Authors:  Haruhiko Nakamura; Sugishita Kazuyuki; Norihito Kawasaki; Masahiko Taguchi; Harubumi Kato
Journal:  Ann Thorac Cardiovasc Surg       Date:  2005-12       Impact factor: 1.520

7.  A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201).

Authors:  Kenji Suzuki; Teruaki Koike; Takashi Asakawa; Masahiko Kusumoto; Hisao Asamura; Kanji Nagai; Hirohito Tada; Tetsuya Mitsudomi; Masahiro Tsuboi; Taro Shibata; Haruhiko Fukuda; Harubumi Kato
Journal:  J Thorac Oncol       Date:  2011-04       Impact factor: 15.609

8.  Survival of 1737 lobectomy-tolerable patients who underwent limited resection for cStage IA non-small-cell lung cancer.

Authors:  Motoki Yano; Junji Yoshida; Terumoto Koike; Kotaro Kameyama; Akira Shimamoto; Wataru Nishio; Kentaro Yoshimoto; Tomoki Utsumi; Takayuki Shiina; Atsushi Watanabe; Yasushi Yamato; Takehiro Watanabe; Yusuke Takahashi; Makoto Sonobe; Hiroaki Kuroda; Makoto Oda; Masayoshi Inoue; Masayuki Tanahashi; Hirofumi Adachi; Masao Saito; Masataro Hayashi; Hajime Otsuka; Teruaki Mizobuchi; Yasumitsu Moriya; Mamoru Takahashi; Shigeto Nishikawa; Yuki Matsumura; Satoru Moriyama; Takeshi Nishiyama; Yoshitaka Fujii
Journal:  Eur J Cardiothorac Surg       Date:  2014-04-03       Impact factor: 4.191

9.  Tumor dimension and prognosis in surgically treated lung cancer: for intentional limited resection.

Authors:  Makoto Nonaka; Mitsutaka Kadokura; Shigeru Yamamoto; Daisuke Kataoka; Toshiaki Kunimura; Miki Kushima; Naoya Horichi; Toshihiro Takaba
Journal:  Am J Clin Oncol       Date:  2003-10       Impact factor: 2.339

10.  Limited resection for Stage I lung cancer.

Authors:  U Pastorino; M Valente; V Bedini; M Infante; L Tavecchio; G Ravasi
Journal:  Eur J Surg Oncol       Date:  1991-02       Impact factor: 4.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.